XFOR X4 PHARMACEUTICALS INC
FollowCOMMON STOCK (common), issuer CIK 1501697
2 managers (2 13F filers) reported a position in XFOR shares at 2025-03-31, 83,045 shares in all. 2 filers opened a position and 0 filers sold out during the quarter.
- Managers
- 2
- 13F filers
- 2
- New
- 2
- Added
- 0
- Reduced
- 0
- Sold out
- 0
- Shares held by filers
- 83,045
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- FMR LLC(group FMR LLC)
4,558,616 shares, 4.6% in a 13G/A as of 2026-09-30,0000315066-26-002326
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q1 2025
Filers in the available 13F reports with a share position at 2025-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | 83,015 | $20K | <0.01% | new | 13F-HRTimeline |
| EverSource Wealth Advisors, LLCin group EverSource Wealth Advisors, L… | 30 | $7 | <0.01% | new | 13F-HRTimelineGroup |
Events
FMR LLC and 1 other reporting person reported 4,558,616 XFOR shares, 4.6% of the class, as of 2026-09-30, in a 13G/A filed 2026-10-07. 0000315066-26-002326
Accepted , ingested